Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 30, 2010 08:00 ET | Source: Entest BioMedical Inc.

Bio-Matrix Scientific Group Chairman Sees Future of Stem Cell Therapies Focused on Stem Cell Repositories

SAN DIEGO, Sept. 30, 2010 (GLOBE NEWSWIRE) -- Bio-Matrix Scientific Group Inc. (OTCBB:BMSN) Chairman & CEO David Koos commented today about the future of stem cell therapy and how advances in...
September 21, 2010 08:00 ET | Source: Entest BioMedical Inc.

Entest CEO Blogcast Today at 10:00 am Covering Strategic Rollout of ImenVax(TM) -- an Immuno-Therapeutic Cancer Vaccine for Dogs

Update to Include Strategy on Acquiring Veterinary Clinics for Immediate Revenue Generation and New Sales Channel for Veterinary Therapies Blogcast Scheduled for Today, September 21st at 10:00 am...
September 16, 2010 08:00 ET | Source: Entest BioMedical Inc.

Entest CEO to Conduct Blogcast on Strategic Rollout of ImenVax(TM), Company's Immuno-Therapeutic Cancer Vaccine for Dogs

Provides Update on Strategy to Acquire Veterinary Clinics for Immediate Revenue Generation and New Sales Channel for Veterinary Therapies Blogcast Scheduled for Tuesday, September 21st at 10:00...
August 18, 2010 08:00 ET | Source: Entest BioMedical Inc.

Entest BioMedical has Identified Several Veterinary Clinics as Possible Acquisition Candidates to Serve as Distribution Channel for Veterinary Therapeutic Treatments

Clinics to Serve as Platform for Launching New 'Veterinary First' Pharmaceuticals Entest Seeks to Acquire 5 Veterinary Clinics with a Total Target Revenue of Over $4 Million SAN DIEGO –...
July 29, 2010 09:00 ET | Source: Entest BioMedical Inc.

Entest BioMedical Finalizing Protocols for ImenVax(TM) Safety Study

Anticipates Commencing Study in Late September 2010 Represents Final Required Step Prior to Commercialization of Immuno-Therapeutic Cancer Vaccine for Dogs SAN DIEGO , July 29, 2010 (GLOBE...
July 27, 2010 09:04 ET | Source: Entest BioMedical Inc.

Entest BioMedical Retains Crescendo Communications as Investor Relations and Corporate Communications Advisor

SAN DIEGO, July 27, 2010 (GLOBE NEWSWIRE) -- Entest BioMedical Inc. (OTCBB:ENTB) today announced that it has retained Crescendo Communications, LLC ("Crescendo") as its investor relations firm to help...